Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine

Objective : The aim of this study was to explore the clinical characteristics of renal metastatic cancer, the methods for its detection by radioiodine (131I), and the response to 131I treatment in fourteen patients with renal metastases from differentiated thyroid carcinoma (DTC).Subjects and methods : DTC patients (n = 2,955) that received treatment with 131I were retrospectively analyzed. Scans (131I-WBS, 31I-SPECT/CT and/or 18F-FDG-PET/CT) were performed after an oral therapeutic dose of 131I. Therapeutic efficacy was evaluated based on changes in Tg and anatomical imaging changes at renal lesions.Results : Among these 14 patients, 11 had avidity for 131I, but three patients did not accumulate 131I after 131I treatment. In the 11 131I-positive renal lesions, 10 cases were detected by 131I-SPECT/CT combined with another imaging modality and one case by 131I-WBS combined with ultrasonography (US). In the three 131I-negative renal lesions, two cases were detected by 18F-FDG-PET/CT and one case by computed tomography (CT). In 11 patients with 131I-avid renal metastases, Serum Tg levels in 81.82% (9/11) patients showed a gradual decline, and 18.18% (2/11) of the patients showed a significant elevation. There was no marked difference in serum Tg before the last 131I treatment (Z = 0.157; p = 0.875). Only one patient presented partial response, eight patients exhibited stable disease, and renal metastases progressed in two patients showing progressive disease. No patients reached complete response.Conclusion : 131I-SPECT/CT, combined with another imaging modality after 131I-WBS, can contribute to the early detection of renal metastases of DTC. 131I therapy is a feasible and effective treatment for most DTC renal metastases with avidity for 131I. Arq Bras Endocrinol Metab. 2014;58(3):260-9

Saved in:
Bibliographic Details
Main Authors: Qiu,Zhong-Ling, Xue,Yan-Li, Luo,Quan-Yong
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000300260
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-27302014000300260
record_format ojs
spelling oai:scielo:S0004-273020140003002602014-05-20Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodineQiu,Zhong-LingXue,Yan-LiLuo,Quan-Yong Differentiated thyroid cancer renal metastases radioiodine therapy 131I-SPECT/CT 18F-FDG-PET/CT Objective : The aim of this study was to explore the clinical characteristics of renal metastatic cancer, the methods for its detection by radioiodine (131I), and the response to 131I treatment in fourteen patients with renal metastases from differentiated thyroid carcinoma (DTC).Subjects and methods : DTC patients (n = 2,955) that received treatment with 131I were retrospectively analyzed. Scans (131I-WBS, 31I-SPECT/CT and/or 18F-FDG-PET/CT) were performed after an oral therapeutic dose of 131I. Therapeutic efficacy was evaluated based on changes in Tg and anatomical imaging changes at renal lesions.Results : Among these 14 patients, 11 had avidity for 131I, but three patients did not accumulate 131I after 131I treatment. In the 11 131I-positive renal lesions, 10 cases were detected by 131I-SPECT/CT combined with another imaging modality and one case by 131I-WBS combined with ultrasonography (US). In the three 131I-negative renal lesions, two cases were detected by 18F-FDG-PET/CT and one case by computed tomography (CT). In 11 patients with 131I-avid renal metastases, Serum Tg levels in 81.82% (9/11) patients showed a gradual decline, and 18.18% (2/11) of the patients showed a significant elevation. There was no marked difference in serum Tg before the last 131I treatment (Z = 0.157; p = 0.875). Only one patient presented partial response, eight patients exhibited stable disease, and renal metastases progressed in two patients showing progressive disease. No patients reached complete response.Conclusion : 131I-SPECT/CT, combined with another imaging modality after 131I-WBS, can contribute to the early detection of renal metastases of DTC. 131I therapy is a feasible and effective treatment for most DTC renal metastases with avidity for 131I. Arq Bras Endocrinol Metab. 2014;58(3):260-9info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArquivos Brasileiros de Endocrinologia & Metabologia v.58 n.3 20142014-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000300260en10.1590/0004-2730000002913
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Qiu,Zhong-Ling
Xue,Yan-Li
Luo,Quan-Yong
spellingShingle Qiu,Zhong-Ling
Xue,Yan-Li
Luo,Quan-Yong
Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
author_facet Qiu,Zhong-Ling
Xue,Yan-Li
Luo,Quan-Yong
author_sort Qiu,Zhong-Ling
title Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
title_short Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
title_full Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
title_fullStr Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
title_full_unstemmed Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
title_sort rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine
description Objective : The aim of this study was to explore the clinical characteristics of renal metastatic cancer, the methods for its detection by radioiodine (131I), and the response to 131I treatment in fourteen patients with renal metastases from differentiated thyroid carcinoma (DTC).Subjects and methods : DTC patients (n = 2,955) that received treatment with 131I were retrospectively analyzed. Scans (131I-WBS, 31I-SPECT/CT and/or 18F-FDG-PET/CT) were performed after an oral therapeutic dose of 131I. Therapeutic efficacy was evaluated based on changes in Tg and anatomical imaging changes at renal lesions.Results : Among these 14 patients, 11 had avidity for 131I, but three patients did not accumulate 131I after 131I treatment. In the 11 131I-positive renal lesions, 10 cases were detected by 131I-SPECT/CT combined with another imaging modality and one case by 131I-WBS combined with ultrasonography (US). In the three 131I-negative renal lesions, two cases were detected by 18F-FDG-PET/CT and one case by computed tomography (CT). In 11 patients with 131I-avid renal metastases, Serum Tg levels in 81.82% (9/11) patients showed a gradual decline, and 18.18% (2/11) of the patients showed a significant elevation. There was no marked difference in serum Tg before the last 131I treatment (Z = 0.157; p = 0.875). Only one patient presented partial response, eight patients exhibited stable disease, and renal metastases progressed in two patients showing progressive disease. No patients reached complete response.Conclusion : 131I-SPECT/CT, combined with another imaging modality after 131I-WBS, can contribute to the early detection of renal metastases of DTC. 131I therapy is a feasible and effective treatment for most DTC renal metastases with avidity for 131I. Arq Bras Endocrinol Metab. 2014;58(3):260-9
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000300260
work_keys_str_mv AT qiuzhongling rarerenalmetastasesfromdifferentiatedthyroidcarcinomaearlyclinicaldetectionandtreatmentbasedonradioiodine
AT xueyanli rarerenalmetastasesfromdifferentiatedthyroidcarcinomaearlyclinicaldetectionandtreatmentbasedonradioiodine
AT luoquanyong rarerenalmetastasesfromdifferentiatedthyroidcarcinomaearlyclinicaldetectionandtreatmentbasedonradioiodine
_version_ 1756372768642826240